The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Journal of Heart Failure

• Publication date

  2011-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/eurjhf/hfr085PMID 21771823
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures: Results From the REPLACE Registry

  2011cited by this paper
• 2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure

  2011cited by this paper
• Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures: Results From the REPLACE Registry

  2010cited by this paper
• Intramural dyssynchrony and response to cardiac resynchronization therapy in patients with and without previous right ventricular pacing

  2010cited by this paper
• Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling.

  2010cited by this paper
• Device‐Related Infection Among Patients With Pacemakers and Implantable Defibrillators: Incidence, Risk Factors, and Consequences

  2010cited by this paper
• 2010 Focused Update of ESC Guidelines on device therapy in heart failure

  2010cited by this paper
• Cardiac-resynchronization therapy for mild-to-moderate heart failure.

  2010influential reference
• The European cardiac resynchronization therapy survey.

  2009cited by this paper
• Cardiac-resynchronization therapy for the prevention of heart-failure events.

  2009cited by this paper
• Biventricular pacing in patients with bradycardia and normal ejection fraction.

  2009cited by this paper
• Guidelines for device-based therapy of cardiac rhythm abnormalities.

  2009cited by this paper
• Upgrade and de novo cardiac resynchronization therapy: impact of paced or intrinsic QRS morphology on outcomes and survival.

  2009cited by this paper
• European cardiac resynchronization therapy survey: rationale and design

  2009cited by this paper
• Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

  2008cited by this paper
• ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.

  2008cited by this paper
• Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications.

  2008cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ‡

  2008cited by this paper
• ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker

  2008cited by this paper
• Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads

  2008cited by this paper
• Hemodynamics and Prognosis after Primary Cardiac Resynchronization System Implantation Compared to “Upgrade” Procedures

  2008cited by this paper
• Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.

  2007cited by this paper
• Biventricular Versus Right Ventricular Pacing in Patients with AV Block (BLOCK HF): Clinical Study Design and Rationale

  2007cited by this paper
• Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.

  2007cited by this paper
• Upgrading from Single Chamber Right Ventricular to Biventricular Pacing in Permanently Paced Patients with Worsening Heart Failure: The RD‐CHF Study

  2007cited by this paper
• [European practice guidelines on cardiac pacemakers and cardiac resynchronization therapy. Working Group of the European Society of Cardiology (ESC) on cardiac pacemakers and cardiac resynchronization therapy. Developed in collaboration with the European Heart Rhythm Association].

  2007cited by this paper
• Biventricular pacemaker upgrade in previously paced heart failure patients--improvements in ventricular dyssynchrony.

  2006cited by this paper
• Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation.

  2006cited by this paper
• The effect of cardiac resynchronization on morbidity and mortality in heart failure.

  2005cited by this paper
• Permanent pacing is a risk factor for the development of heart failure.

  2005cited by this paper
• Effect of chronic right ventricular apical pacing on left ventricular function.

  2005cited by this paper
• Detrimental Ventricular Remodeling in Patients With Congenital Complete Heart Block and Chronic Right Ventricular Apical Pacing

  2004cited by this paper
• Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

  2004cited by this paper
• Interventricular and intra-left ventricular electromechanical delays in right ventricular paced patients with heart failure: implications for upgrading to biventricular stimulation

  2003cited by this paper
• The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population.

  2003cited by this paper
• Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction

  2003cited by this paper
• Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.

  2002cited by this paper
• Cardiac resynchronization in chronic heart failure.

  2002cited by this paper
• Functional abnormalities in patients with permanent right ventricular pacing: the effect of sites of electrical stimulation.

  2002cited by this paper
• Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.

  2001cited by this paper
• Myocardial perfusion in patients with permanent ventricular pacing and normal coronary arteries.

  2001cited by this paper
• Long-term effect of right ventricular pacing on myocardial perfusion and function.

  1997cited by this paper
• Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome.

  1997cited by this paper
• Effects of long-term right ventricular apical pacing on left ventricular perfusion, innervation, function and histology.

  1994cited by this paper
• Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality.

  1988cited by this paper

• A Perspective on the Emerging Preventive and Therapeutic Strategies in Pacemaker-Induced Cardiomyopathy: A Systematic review of the literature.

  2025cites this paper
• A Beating‐Heart Procedure with Soft Robotic Guidance

  2025cites this paper
• Linksventrikuläre Elektrodenimplantation im Rahmen der kardialen Resynchronisationstherapie

  2025cites this paper
• Optimization of Cardiac Resynchronization Therapy: Comparison of Acoustic Cardiography and Echocardiographic Methods for Optimizing the Implanted Cardiac System

  2025cites this paper
• Right Ventricular Apical (RVA) Pacing-Induced Cardiomyopathy Disguised As Ischemic Cardiomyopathy: A Case Report

  2025cites this paper
• Endokardiale linksventrikuläre Stimulation im Jahr 2025

  2025cites this paper
• De Novo Versus Upgrade Cardiac Resynchronization Therapy in Patients with Heart Failure: A Cohort Study

  2024cites this paper
• Labor Market Participation Among Working-Age Heart Failure Patients With a Cardiac Resynchronization Therapy Device

  2024cites this paper
• Comparative Analysis of Response to Cardiac Resynchronisation Therapy Upgrades in Patients with Implantable Cardioverter-Defibrillators and Pacemakers

  2024cites this paper
• New Insights into Pacing Induced Cardiomyopathy

  2024cites this paper
• Terapia de Ressincronização Cardíaca de Novo versus Upgrade em Pacientes com Insuficiência Cardíaca: Estudo de Coorte

  2024cites this paper
• A multifunctional soft robot for cardiac interventions

  2023cites this paper
• Long‐term outcome after upgrade to cardiac resynchronization therapy: A propensity score‐matched analysis

  2023cites this paper
• Long-term outcomes from upgrade to cardiac resynchronisation therapy in ischaemic versus non-ischaemic heart disease

  2023cites this paper
• Conduction system pacing, a European survey: insights from clinical practice

  2023cites this paper
• Anticoagulant therapy during cardiovascular implantable electronic device procedures

  2023cites this paper
• Imaging in patients with cardiovascular implantable electronic devices - Part 2: Imaging after device implantation.

  2023cites this paper
• Upgrading right ventricular pacemakers to biventricular pacing or conduction system pacing: a systematic review and meta-analysis

  2022cites this paper
• 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Translation of the document prepared by the Czech Society of Cardiology

  2022cites this paper
• Complications of cardiac resynchronization therapy implantation: De novo implants versus upgrades

  2022cites this paper
• A new era: Speckle tracking echocardiography and cardiomyopathies

  2022cites this paper
• Long-term survival following upgrade compared with de novo cardiac resynchronization therapy implantation: a single-centre, high-volume experience

  2021cites this paper
• Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis

  2021cites this paper
• 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.

  2021cites this paper
• Желудочковые нарушения ритма. Желудочковые тахикардии и внезапная сердечная смерть. Клинические рекомендации 2020

  2021cites this paper
• 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.

  2021cites this paper
• Leadless left ventricular endocardial pacing for CRT upgrades in previously failed and high-risk patients in comparison with coronary sinus CRT upgrades

  2021cites this paper
• Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.

  2021cites this paper
• Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines

  2021cites this paper
• Upgrading to cardiac resynchronisation therapy: Concordance of real-world experience with clinical guidelines☆

  2021cites this paper
• Comparison of de novo versus upgrade cardiac resynchronisation therapy on clinical effect and long-term outcome

  2021cites this paper
• Long-term clinical outcomes after upgrade to resynchronization therapy: A propensity score–matched analysis

  2021influential citation
• Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes.

  2020cites this paper
• Survival of patients with pacing‐induced cardiomyopathy upgraded to CRT does not depend on defibrillation therapy

  2020cites this paper
• A Comparison of Left Ventricular Lead Upgrade versus Continued Medical Care Among Patients Eligible for Cardiac Resynchronization Therapy at the Time of Defibrillator Generator Replacement: Predictors of Left Ventricular Lead Upgrade and Associations with Long-term Outcomes.

  2020cites this paper
• Cardiac Device Infections: A Lesson from the Registries

  2020cites this paper
• Comparative Analysis of Procedural Outcomes and Complications Between De Novo and Upgraded Cardiac Resynchronization Therapy.

  2020cites this paper
• New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure—Targeting the Sympathetic Nervous System

  2019cites this paper
• Mortality and Heart Failure After Upgrade to Cardiac Resynchronization Therapy

  2019influential citation
• CAPABILITIES OF 123I-MIBG SCINTIGRAPHY AND GATED BLOOD-POOL SPECT IN PREDICTING THE RESULTS OF CARDIAC RESYNCHRONIZATION THERAPY

  2019cites this paper
• Long term outcomes in patients with chronic right ventricular pacing upgraded to cardiac resynchronization therapy

  2019influential citation
• Clinical impact of antithrombotic therapy in transvenous lead extraction complications: a sub-analysis from the ESC-EORP EHRA ELECTRa (European Lead Extraction ConTRolled) Registry.

  2019cites this paper
• Implant of Cardiac Resynchronization Therapy Device in Patients with High Percentage of Right Ventricular Pacing and Refractory Heart Failure

  2018cites this paper
• Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II

  2018cites this paper
• 8 – Transvenous Lead Placement

  2018cites this paper
• Implant of Cardiac Resynchronization Therapy Device in Patients with High Percentage of Right Ventricular Pacing and Refractory Heart Failure

  2018cites this paper
• Sondenlose endokardiale linksventrikuläre Stimulation

  2018cites this paper
• T wave positivity in lead aVR is associated with mortality in patients with cardiac resynchronization therapy

  2018cites this paper
• Managing anticoagulation in patients receiving implantable cardiac devices.

  2018cites this paper
• Natural progression of QRS duration in ICD-only patients

  2018cites this paper
• Complications associated with cardiac resynchronization therapy upgrades versus de novo implantations

  2018influential citation
• Sondenlose endokardiale linksventrikuläre Stimulation WiSE TM CRT-System : Alternative zu herkömmlichen

  2018cites this paper
• Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis

  2018cites this paper
• Long-Term Outcome After CRT in the Presence of Mechanical Dyssynchrony Seen With Chronic RV Pacing or Intrinsic LBBB.

  2017cites this paper
• Cardiac Resynchronization Therapy Upgrade: Verschlimmbesserung?

  2017cites this paper
• De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis

  2017influential citation
• Trends and outcomes of cardiac resynchronization therapy upgrade procedures: A comparative analysis using a United States National Database 2003-2013.

  2017cites this paper
• The right timing for the left lead: Now or later?

  2017cites this paper
• Long‐term outcomes of heart failure patients who received primary prevention implantable cardioverter‐defibrillator: An observational study

  2017cites this paper
• Comparison of De Novo versus Upgrade Cardiac Resynchronization Therapy; Focused on the Upgrade for Pacing-Induced Cardiomyopathy

  2017cites this paper
• Efficacy and safety of the subcutaneous implantable cardioverter defibrillator: a systematic review

  2017cites this paper
• Effects of Upgrade Versus De Novo Cardiac Resynchronization Therapy on Clinical Response and Long-Term Survival: Results from a Multicenter Study

  2017cites this paper
• Association between demographic, organizational, clinical, and socio‐economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry

  2017cites this paper
• Obstacles preventing biventricular pacing mitigated with lead extraction and His bundle pacing to achieve effective cardiac resynchronization

  2017cites this paper
• Optimisation of pacemaker therapy for cardiac function

  2017cites this paper
• 18 – Cardiac Resynchronization Therapy

  2017cites this paper
• A brief overview of cardiac resynchronization therapy and its current use in clinical practice

  2017cites this paper
• Evaluation of wireless stimulation of the endocardium, WiSE, technology for treatment heart failure

  2016cites this paper
• Pacing‐Induced Cardiomyopathy: “It's Tough to Make Predictions, Especially About the Future” **

  2016cites this paper
• Comparative long-term outcomes after cardiac resynchronization therapy in right ventricular paced patients versus native wide left bundle branch block patients.

  2016cites this paper
• Managing periprocedural anticoagulation therapy in patients undergoing device implantation: survey in Germany, Austria and Switzerland.

  2016cites this paper
• Long‐Term Impact of Right Ventricular Pacing on Left Ventricular Systolic Function in Pacemaker Recipients With Preserved Ejection Fraction: Results From a Large Single‐Center Registry

  2016cites this paper
• Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial

  2016cites this paper
• Kardiale Resynchronisation (CRT)

  2016cites this paper
• “Are CRT upgrade procedures more complex and associated with more complications than de novo CRT implantations?” A single centre experience

  2015influential citation
• Routine use of biventricular pacing is not warranted for patients with heart block.

  2015cites this paper
• The Role of Biventricular Pacing in the Prevention and Therapy of Pacemaker‐Induced Cardiomyopathy

  2015cites this paper
• Should all patients with heart block receive biventricular pacing? All heart block patients with a pacemaker indication should receive biventricular pacing: one move, double the gains?

  2015cites this paper
• Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.

  2015cites this paper
• Incidence, Predictors, and Procedural Results of Upgrade to Resynchronization Therapy: The RAFT Upgrade Substudy

  2015cites this paper
• Upgrading and replacement in CRT devices: experience counts

  2015cites this paper
• The changing landscape of cardiac pacing

  2015cites this paper
• Management of antithrombotic therapy in patients undergoing electrophysiological device surgery.

  2015cites this paper
• Longevity of the Subcutaneous Implantable Defibrillator: Long-Term Follow-Up of the European Regulatory Trial Cohort

  2015influential citation
• Cardiac resynchronization therapy is appropriate for all patients requiring chronic right ventricular pacing: the pro perspective.

  2015cites this paper
• Detect Long‐term Complications After ICD Replacement (DECODE): Rationale and Study Design of a Multicenter Italian Registry

  2015cites this paper
• Cardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunction

  2015cites this paper
• Biventricular pacing for bradycardia: are we there yet?

  2015cites this paper
• Pedoman Terapi Memakai Alat Elektronik Kardiovaskular Implan (Aleka) Perhimpunan Dokter Spesialis Kardiovaskular Indonesia 2014

  2015cites this paper
• Patients with long-term permanent pacemakers have a high prevalence of left ventricular dysfunction

  2015cites this paper
• An unusual defibrillator lead complication identified at explant.

  2014cites this paper
• Guía de práctica clínica de la ESC 2013 sobre estimulación cardiaca y terapia de resincronización cardiaca

  2014cites this paper
• Terapia de resincronización cardíaca: experiencia a diez años y análisis de la evolución clínica de los pacientes en un centro de nuestro país

  2014cites this paper
• Pacing-associated left ventricular dysfunction? Think reprogramming first!

  2014cites this paper
• ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

  2014cites this paper
• Echocardiographic and clinical response to cardiac resynchronization therapy in heart failure patients with and without previous right ventricular pacing

  2014cites this paper
• 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.

  2014cites this paper
• Long‐term follow‐up results of the Pacing to Avoid Cardiac Enlargement (PACE) trial

  2014cites this paper
• How do patients with previous RV pacing respond to upgrading to CRT? Important messages for pacemaker and ICD follow‐up

  2014cites this paper
• Upgrading pacemaker to cardiac resynchronization therapy: an option for patients with chronic right ventricular pacing and heart failure.

  2014cites this paper